| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.75B | +13.0% | +71.3% |
| Cost of Revenue | $4.62B | — | +71.5% |
| Gross Profit | $1.12B | +25.6% | +70.6% |
| R&D Expense | $46.0M | — | +64.3% |
| SG&A Expense | $435.0M | — | +38.1% |
| Operating Income | $461.0M | — | +47.8% |
| Pre-tax Income | $309.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $825.0M | -0.2% | +91.0% |
| Accounts Receivable | $3.43B | +0.1% | +73.8% |
| Current Assets | $8.53B | +1.1% | +62.8% |
| Total Assets | $37.15B | +0.2% | +119.7% |
| Current Liabilities | $8.19B | +17.1% | +101.2% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$133.0M | — | +50.6% |
| Investing Cash Flow | -$226.0M | — | -45.8% |
| Financing Cash Flow | $358.0M | — | +51.1% |
| +30.9% |
| Income Tax | $49.0M | — | +14.0% |
| Net Income | $262.0M | +771.8% | +37.2% |
| EPS (Basic) | $0.11 | +694.7% | -14.4% |
| EPS (Diluted) | $0.11 | — | -14.4% |
| $12.82B |
| -7.4% |
| +78.7% |
| Total Liabilities | $25.42B | +0.4% | +96.8% |
| Stockholders' Equity | $11.72B | -0.1% | +199.0% |